Quarterly Results

  • Company Name :
Biocon Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 532523
  • NSE Symbol:
  • BIOCON
  • P/E(TTM):
  • -
  • ISIN Demat:
  • INE376G01013
  • Div & Yield%:
  • 0.13
  • EPS(TTM):
  • 0.09
  • Book Value(₹):
  • 119.85
  • Market Cap(₹Cr.):
  • 47,716.23
  • Face Value(₹):
  • 5.00
Quarters :  
Particulars June 2025 ( Cr)March 2025 ( Cr)December 2024 ( Cr)
Gross Sales 537.10 643.80 562.80
Excise Duty 0.00 0.00 0.00
Net Sales 537.10 643.80 562.80
Other Operating Income 0.00 0.00 0.00
Other Income 61.30 62.70 671.70
Total Income 598.40 706.50 1,234.50
Total Expenditure 516.50 581.80 531.50
PBIDT 81.90 124.70 703.00
Interest 56.20 56.70 65.30
PBDT 25.70 68.00 637.70
Depreciation 33.30 33.00 33.80
Tax 1.10 26.50 8.40
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -0.40 -12.70 11.50
Reported Profit After Tax -8.30 21.20 584.00
Extra-ordinary Items 0.00 0.00 587.60
Adjusted Profit After Extra-ordinary item -8.30 21.20 -3.60
EPS (Unit Curr.) -0.07 0.18 4.88
EPS (Adj) (Unit Curr.) -0.07 0.18 4.88
Calculated EPS (Unit Curr.) -0.06 0.18 4.86
Calculated EPS (Adj) (Unit Curr.) -0.06 0.18 4.86
Calculated EPS (Ann.) (Unit Curr.) -0.25 0.71 19.46
Calculated EPS (Adj) (Ann.) (Unit Curr.) -0.25 0.71 19.46
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 668.50 600.30 600.30
Reserve & Surplus 0.00 0.00 0.00
Face Value 5.00 5.00 5.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) 15.25 19.37 124.91
PBDTM(%) 4.78 10.56 113.31
PATM(%) -1.55 3.29 103.77